產品詳情
查看大圖

  • 產品名稱：CRL-2095 CAL 27 人舌鱗癌細胞

  • 產品型號：CRL-2095 CAL 27
  • 產品廠商：其它品牌
  • 產品文檔：
你添加了1件商品 查看購物車
簡單介紹：
簡單介紹 CRL-2095 CAL 27 人舌鱗癌細胞，ATCC 細胞|細胞係|細胞株|細胞,細胞庫管理規範，提供的細胞株背景清楚，提供參考文獻和**培養條件。
詳情介紹：
CRL-2095 CAL 27 人舌鱗癌細胞 的詳細介紹
CRL-2095 CAL 27 人舌鱗癌細胞
ATCC® Number: CRL-2095™  Price:  
Designations: CAL 27
Depositors: C Cardona
Biosafety Level: 1
Shipped: frozen
Medium & Serum: See Propagation
Growth Properties: adherent
Organism: Homo sapiens (human)
Morphology: epithelial
Source: Organ: tongue 
Disease: squamous cell carcinoma
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
 
Isolation: Isolation date: 1982
Tumorigenic: Yes
DNA Profile (STR): Amelogenin: X 
CSF1PO: 10,12 
D13S317: 10,11 
D16S539: 11,12 
D5S818: 11,12 
D7S820: 10 
THO1: 6,9.3 
TPOX: 8 
vWA: 14,17
Cytogenetic Analysis: aneuploid; modal number = 43
Age: 56 years
Gender: male
Ethnicity: Caucasian
Comments: Cal 27 was established in 1982 by J. Gioanni (Centre Antoine Lacassagne, Nice Cedex, France) from tissue taken prior to treatment from a 56 year old Caucasian male with a lesion of the middle of the tongue. 
CAL 27 cells are epithelial, polygonal with a highly granular cytoplasm. 
Immunocytochemical studies show strong positive staining with anti keratin antibodies. 
The cells do not grow well in semi-solid medium. 
Marked inhibition of thymidine incorporation was observed in the presence of VP16 (etoposide), CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea), VM26 (teniposide), ADM (adriamycin), CPA (cyclophosphamide), and MTX (methotrexate). 
CAL 27 cells were resistant to treatment with VDS (vindesine sulfate), CDP (cis-platinum) or ACTD (actinomycin D). 
A culture submitted to the ATCC in December 1993 was found to be contaminated with mycoplasma. Progeny were cured by a 21-day treatment with BM Cycline.
Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Temperature: 37.0°C
Subculturing: Protocol: Remove spent medium, add fresh 0.25% trypsin, 0.53 mM EDTA solution, rinse and remove trypsin. Add fresh trypsin and let the culture sit at room temperature (or at 37C) until the cells detach. Add fresh medium, aspirate and dispense into new flasks. 
Subcultivation Ratio: A subcultivation ratio of 1:6 is recommended 
Medium Renewal: Every 2 to 3 days
Preservation: Freeze medium: Complete growth medium, 95%; DMSO, 5% 
Storage temperature: liquid nitrogen vapor temperature
Doubling Time: 35 hrs
Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2002
recommended serum:ATCC 30-2020
References: 23521: Gioanni J, et al. Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment. Eur. J. Cancer Clin. Oncol. 24: 1445-1455, 1988. PubMed: 3181269

滬公網安備 31010902002433號